compound introduction
CA-170 is an orally delivered dual inhibitor of VISTA and PD-L1 . CA-170 exhibits potent rescue of proliferation and effector functions of T cells inhibited by PD-L1/L2 and VISTA with selectivity over other immune checkpoint proteins as well as a broad panel of receptors and enzymes. Form:Solid IC50& Target:PD-1 In Vitro:CA-170 exhibits potent functional activity in rescuing T-cell proliferation and effector functions, while showing selectivity against other immune checkpoint proteins as well as in a broad panel of receptors and enzymes. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
